Johnson & Johnson (JNJ) is eyeing an acquisition of Ollin Biosceinces for up to USD 3.4bn, according to FT
Newsquawk Staff ·
Johnson & Johnson (JNJ) is eyeing an acquisition of Ollin Biosceinces for up to USD 3.4bn, according to FT.
What it means
Large-cap pharma bolt-ons of this size are a well-worn pattern for J&J, which has historically used its balance sheet to buy pipeline rather than build it, particularly as patent cliffs on established products approach. The 'up to' construction indicates a structure with milestones or contingent consideration, common in early-stage biotech deals, where only part of the headline number is paid upfront and the rest is tied to clinical or regulatory events; the distinction matters for cash flow timing and for how much of the value is actually at risk on day one. Deals of this scale relative to the acquirer's market cap have tended to be absorbed without material moves in the buyer's shares, with the more telling reaction in the target and in peers holding comparable assets, where read-through on valuation benchmarks has historically lifted the subsector. Worth watching is whether the report is confirmed with terms, whether competing bidders emerge, a recurring feature once a process leaks to press, and how the asset fits the acquirer's stated therapeutic priorities, since deals outside core areas have more often been revisited later. As an unconfirmed press report at this stage, the signal is directional rather than executable.
Sources
- US Market Wrap: Tech leads losses; Hawkish Fed bets trimmed on soft headline PPI
- US FX WRAP: DXY rally continues in preferred haven bid; USD/JPYJPY again little changed
- Newsquawk European Market Wrap - 13th November 2026
- US EQUITY OPEN: Indices pare gains as Tech once again underperforms
- Daily US Equity Opening News: MSFT outage recovery continues; ANT IPO 6x oversubscribed; NSCL needs more financing for ANT deal
Related headlines
- TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 8 + TICKS LOWER AT 105-062 days ago
- White House Official says US President Trump to extend shipping waiver for oil and fertilizer for 90 days2 days ago
- US President Trump is reportedly push Southeast Asian countries to join Pax Silica at ASEAN summit, SCMP reports2 days ago
- Newsquawk Weekly Economic Release 16th - 20th November 20262 days ago
- Some of US President Trump's advisers have discussed whether Commerce Secretary Lutnick should be dismissed, reports CNN citing sources; Trump has also received calls from officials and outside advisers raising concerns about Lutnick2 days ago
- FDA approves AstraZeneca’s (AZN LN) Imfinzi plus Pfizer (PFE) and Astellas’ (4503 JT) Padcev for muscle-invasive bladder cancer six weeks ahead of schedule2 days ago
- Mossad Director is in Washington on Friday for talks with senior Trump administration officials on the Iran war, Axios reports, citing three sources2 days ago
- [MARKET UPDATE] US equity futures begin with mild gains (Emini S&P +0.1%, Emini Nasdaq 100 +0.4%), while T-note futures are flat and WTI is marginally lower (-0.3%) in a muted start to the week as participants await incoming data and key meetings1 hour ago
- PRE-MARKET AUSTRALIAN STOCKS NEWS: Elders (ELD AT) FY26 (AUD) net nearly tripled to 144.2mln, New Hope Corporation (NHC AT) Q1 FY27 saleable coal output fell 6.4% Q/Q to 2.86mln tonnes, Coles (COL AT) is investigating a cybersecurity incident1 hour ago
- Fed Financial Stability Report: AI is the most-cited risk to the financial system, flagged as a salient risk by 87% of survey respondents2 days ago
- NY Fed says the Desk plans around USD 14bln of reinvestment purchases and no reserve management purchases between November 16th and December 11th2 days ago
- CRUDE WRAP: WTI (Z6) SETTLES USD 0.18 LOWER AT USD 88.56/BBL; BRENT (F7) SETTLES USD 0.02 HIGHER AT USD 95.84/BBL2 days ago
- [MARKET UPDATE] USD/JPY sharply falls from 159.90 to 159.55 2 days ago
- USTR, alongside the US Treasury, held the first official US-China Board of Trade meeting, according to a statement2 days ago
- Fed's Collins (2028 Voter) is laser focused on the data, but does not put too much attention on one report2 days ago